『Oncology Nursing Update with Dr Neil Love: Focus on Oncology Nursing』のカバーアート

Oncology Nursing Update with Dr Neil Love: Focus on Oncology Nursing

Oncology Nursing Update with Dr Neil Love: Focus on Oncology Nursing

著者: Dr. Neil Love
無料で聴く

Medical oncologist Dr Neil Love interviews oncology experts. Free NCPD credit hours are available.Copyright 2026 Dr. Neil Love 科学 衛生・健康的な生活 身体的病い・疾患
エピソード
  • Ovarian Cancer — Proceedings from the 2026 Annual ONS Congress
    2026/07/23

    Featuring perspectives from Dr Bradley J Monk, Dr David M O’Malley, Ms Kathryn M Schlenker and Ms Jaclyn Shaver, moderated by Dr O’Malley, including the following topics:

    • Introduction (00:00)
    • Overview of Ovarian Cancer (OC) (2:12)
    • Role of PARP Inhibitors in Advanced OC (4:56)
    • Current and Potential Future Role of Mirvetuximab Soravtansine in OC (28:45)
    • Role of Relacorilant in Advanced OC (57:08)
    • Utility of Immune Checkpoint Inhibition in Advanced OC (1:14:12)

    NCPD information and select publications

    続きを読む 一部表示
    1 時間 30 分
  • Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia — Proceedings from the 2026 Annual ONS Congress
    2026/07/15

    Featuring perspectives from Dr Farrukh T Awan, Dr Brad S Kahl, Ms Robin Klebig and Ms Mollie Moran, moderated by Dr Kahl, including the following topics:

    • Introduction: Biology of Non-Hodgkin Lymphoma (NHL) (00:00)
    • Current Role of CD20 x CD3 Bispecific Antibodies in NHL (4:49)
    • Role of Polatuzumab Vedotin in Diffuse Large B-Cell Lymphoma (DLBCL) (27:48)
    • Optimal Application of Loncastuximab Tesirine for Patients with DLBCL and Follicular Lymphoma (41:43)
    • Role of Bruton Tyrosine Kinase (BTK) Inhibitors Alone or with Anti-CD20 Antibodies for Patients with Newly Diagnosed Chronic Lymphocytic Leukemia (CLL) (1:00:43)
    • Combining BTK Inhibitors with Bcl-2 Inhibitors (1:31:15)
    • Current and Future Role of Noncovalent BTK Inhibitors in CLL (1:41:30)

    CME information and select publications

    続きを読む 一部表示
    1 時間 58 分
  • Strategies to Safely and Effectively Implement Antibody-Drug Conjugates — Proceedings from the 2026 Annual ONS Congress
    2026/07/06

    Featuring perspectives from Ms Courtney Arn, Ms Jamie Carroll, Dr Edward B Garon, Dr Heather McArthur and Dr Kathleen N Moore, moderated by Dr Moore, including the following topics:

    • Introduction (0:00)
    • Overview of Antibody-Drug Conjugates (ADCs) (2:07)
    • Current and Future Role of HER2-Targeted ADCs for Breast Cancer (6:23)
    • Currently Available ADCs for Gynecologic Cancer Management (26:37)
    • Currently Available ADCs for Lung Cancer Management (44:07)
    • Current and Future Role of TROP2-Targeted ADCs for Metastatic Breast Cancer (56:55)
    • Other ADCs That May Soon Reach the Clinic for Advanced Gynecologic Cancers (1:15:07)
    • Promising Investigational Strategies Employing ADCs for Lung Cancer (1:25:01)

    NCPD information and select publications

    続きを読む 一部表示
    1 時間 29 分
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません